Latest News

  • Supplier Visit - WERFEN   -   2021-10-20
    Supplier Visit - WERFEN

    Within the deep business relationship between AFMS & our strategic partner WERFEN, we had the pleasure of WERFEN top management team visit in person after long time of COVID restrictions.

    Mr. Pepe Zamora – (WERFEN business director) & Mr. Oscar Marquez – (MEA Country Manager), on 12th – 14th of October visited Riyadh Office and during the visit several meetings were directed with Mr. Hussein Fares (CEO - AFC), and AFMS top management, discussing the current business achievements and future growth plans, and agreed on the importance of strengthening our partnership in all aspects during their visit, some market meetings were conducted to key customers such as PSMMC, KSMC, where they touched the great efforts made by AFMS team and felt the value delivered to KSA clients such activities had impacted in a very positive way for both sides and resulted in a solid roadmap for future successes.

     

  • New Insights in Covid – 19 Serology Testing Webinar   -   2021-10-05
    New Insights in Covid – 19 Serology Testing  Webinar

    The cooperation between Abdulla Fouad for Medical Supplies and Services Company” AFMS” and DiaSorin to improve the awareness about the importance of COVID-19 serology testing and to know the latest update about this technology according to international guidelines , we conducted a webinar in Monday 20th of September 2021 about “New Insights in Covid-19 Serology Testing” presented by Dr. Sonia Allibardi - Corporate Marketing Director Respiratory Diseases in DiaSorin  who explained  about Anti-SARS-CoV-2 Antibodies Testing in Recipients of COVID-19 Vaccination “Why, When and How”, also shared the Role of the SARS-CoV-2 TrimericS IgG antibody assay in the immune response monitoring in post-vaccination, post-infection. The outcomes were more than 800 registrations and around 500 attendees.

     

    The LIAISON®️ SARS-CoV-2 TrimericS IgG assay uses chemiluminescence immunoassay (CLIA) technology for the quantitative determination of anti-trimeric spike protein specific IgG antibodies to SARS-CoV-2 in human serum or plasma samples. The assay is intended as an aid in the diagnosis of CoVID-19 and to support the study of the immune status of infected patients by providing an indication of the presence of neutralizing IgG antibodies against SARS-CoV-2.

  • Sponsorship Agreement between Ministry of Health and Abdulla Fouad Company for Covid-19 Vaccine   -   2021-04-15
    Sponsorship Agreement between Ministry of Health and Abdulla Fouad Company for Covid-19 Vaccine

    Abdulla Fouad Company, represented by the Chairman, Mr. Faisal Abdulla Fouad, has signed a cooperation agreement with the Dammam Health Network Administration in the Eastern Province, which aims to equip Al Baraka Center in Dammam, to be one of the Coronavirus (Covid-19) vaccination centers in the Eastern Province of Saudi Arabia.

  • Abdulla Fouad for Medical Supplies and Services (AFMSS) and Thermo Fisher Scientific – Materials and Structural Analysis Division (MSD) signed a new partnership agreement.   -   2021-02-21
    Abdulla Fouad for Medical Supplies and Services (AFMSS) and Thermo Fisher Scientific – Materials and Structural Analysis Division (MSD) signed a new partnership agreement.

    We are pleased to announce a new partnership between Abdulla Fouad for Medical Supplies and Services (AFMSS) and Thermo Fisher Scientific – MSD EM. The partnership agreement has been signed in the presence of Abdulla Fouad Group Chairman Mr. Faisal Abdulla Fouad, CEO Mr. Hussein Fares, and Thermo Fisher Sales Director of EMEA Mr. Boris Van Gurp and Sr. Business Development Manager of Saudi Arabia Mr. Ahmed Al-Saleh in addition to respected mangers from both parties.

     Thermo Fisher Scientific is the world leader in serving science, delivers an unrivaled combination of innovative technologies and services enabling customers to make the world healthier, cleaner and safer.

     AFMS and Thermo Fisher Scientific – MSD EM are aiming to expand and improve the services for all customers and users of Thermo Fisher Electron Microscopy products. Whether our customers are accelerating life science or materials science research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity and quality control in their laboratories, we look forward to working together to support them. 

    Thermo Fisher Scientific Electron Microscopy will add great value to our portfolio in AFMSS and we are very delighted for starting this great partnership.

  • Partnership between AFMS and LABVANTAGE   -   2020-12-07
    Partnership between AFMS and LABVANTAGE

    AFMS and LabVantage Solutions, Inc. announces a strategic partnership, on December 7th 2020, to introduce LabVantage Medical Suite to the Saudi Arabia market. This strategic partnership will bring AFMS an expansion of its healthcare product portfolio and will increase LabVantage's footprint in the Kingdom of Saudi Arabia.

    LabVantage Medical Suite is entering the local market as a Laboratory Information System (LIS) that integrates all medical laboratory disciplines from chemistry and hematology, pathology and genomics to microbiology and other general lab functions in one platform. LabVantage Medical Suite is proven in more than 50 hospital and healthcare settings, to streamline the entire laboratory operation, automate routine tasks and processes, reduce errors and overall costs.

  • Werfen EEMEAI – Acute care diagnostics distributor meeting   -   2020-11-23
    Werfen EEMEAI – Acute care diagnostics distributor meeting

    AFMS participate in the Werfen ACDX distributor meeting presenting our experience with Gem (Blood Gas) product, and how we built the market last 5 years increasing the market share for Gem products in Saudi Arabia in MOH, and outside the MOH as we multiply the sales 8 times during the last 5 years with a great efforts from all the team involved.

    Gem is innovative blood gas machine which deliver unique clinical, and health economics value compared with other competitors.  We succeed to demonstrate the unique values to the market which reflect to our market share share last 5 years.

  • Cytiva Service Training   -   2020-10-27
    Cytiva Service Training

    Abdulla Fouad for Medical Supplies and Service (AFMS) manage with Cytiva (Biosafe) to conduct Service Training for all the product line. This training was hybrid in Nature:

      • AFMS Expert Engineer lead the training for the first two days and brief all the theoretical part.
      • Cytiva Engineer conducted three days online training using MS Teams with dedicated advance camera to have the maximum benefit out of this training.

    At the end of the training, three FSEs have successfully pass the exam and get certified to maintain Cytiva Products.

  • AL-BISHRI Makkah Partnership   -   2020-10-19
    AL-BISHRI Makkah Partnership

    AFMS sign contracts with Dr. Awad Al-Bishri (Albishri Group CEO) for complete diagnostics Lab equipment covering all Lab dep. (Chemistry, Serology, Hematology, Microbiology) which provides high end technology in Lab science.
    This partnership will be extended during the coming 5 years providing Al-Bishri will all required machines, reagents, and support. We build this partnership to be a model in the region providing patient care, patient safety with cost effective.